Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis
By: editor, Sydne J. Newberry ... [et al.] ; prepared by:  Southern California/RAND Evidence-based Practice Center, Los Angeles, CA..
Contributors: Carlson-Newberry, Sydne J.; Southern California Evidence-Based Practice Center/RAND.; United States. Agency for Healthcare Research and Quality.
Series: AHRQ publication ;; no 04-E013-2; Evidence report/technology assessment ;; no. 89
Publisher: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
Published: 2004
Place of publication: Rockville, MD
Language: eng
Number of pages: 145
Subjects: Omega-3 fatty acids -- Therapeutic use.; Omega-3 fatty acids -- Health aspects.; Evidence-based medicine.; Meta-analysis.
Notes: Includes bibliographical references.
"March 2004."
"Contract no. 290-02-003."